Attainment of metabolic goals in the integrated UK islet transplant program with locally isolated and transported preparations

American Journal of Transplantation

Volumn 13, Issue 12, 2013, Pages 3236-3243

  Brooks, A M ^a   Walker, N ^b   Aldibbiat, A ^a   Hughes, S ^b   Jones, G ^c   De Havilland, J ^c   Choudhary, P ^d   Huang, G C ^d   Parrott, N ^e   McGowan, N W A ^f   Casey, J ^f   Mumford, L ^g   Barker, P ^h   Burling, K ^h   Hovorka, R ^h   Walker, M ^a   Smith, R M ⁱ   Forbes, S ^f   Rutter, M K ^e,j   Amiel, S ^d   Rosenthal, M J ^c   Johnson, P ^b   Shaw, J A M ^a   more..

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g NHS BLOOD AND TRANSPLANT   (United Kingdom)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ SOUTHMEAD HOSPITAL   (United Kingdom)

^j UNIVERSITY OF MANCHESTER   (United Kingdom)

more..

Author keywords

Islet transplantation; Islet transport; Meal tolerance test; Severe hypoglycemia

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; C PEPTIDE; CREATININE; CYCLOSPORIN A; DACLIZUMAB; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN A1C; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; AWARENESS; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DONOR; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH PROGRAM; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MALE; METABOLISM; NEUTROPENIA; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE; TEST MEAL; TREATMENT OUTCOME; UNITED KINGDOM;

ISLET TRANSPLANTATION; ISLET TRANSPORT; MEAL TOLERANCE TEST; SEVERE HYPOGLYCEMIA;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; GREAT BRITAIN; HUMANS; HYPOGLYCEMIA; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84888344174     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12469     Document Type: Article

References (23)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
2. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060-2069.
3. Barton FB, Rickels MR, Alejandro R, et al. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 2012; 35: 1436-1445.
4. Khan MH, Harlan DM., Counterpoint: Clinical islet transplantation: Not ready for prime time. Diabetes Care 2009; 32: 1570-1574.
5. Aldibbiat A, Huang GC, Zhao M, et al. Validation of islet transport from a Geographically Distant Isolation Center enabling equitable access and National Health Service funding of a Clinical Islet Transplant Program for England. Cell Med 2012; 21: 97-104.
6. Workgroup on Hypoglycemia ADA. Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005; 28: 1245-1249.
7. IPG257, allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus [NICE guidelines], 2008. Available at: http://publications. nice.org.uk/allogeneic-pancreatic-islet-cell-transplantation-for-type-1- diabetes-mellitus-ipg257. Accessed December 12, 2012.
8. Vantyghem MC, Kerr-Conte J, Arnalsteen L, et al. Primary graft function, metabolic control, and graft survival after islet transplantation. Diabetes Care 2009; 32: 1473-1478.
9. Huang GC, Zhao M, Jones P, et al. The development of new density gradient media for purifying human islets and islet-quality assessments. Transplantation 2004; 77: 143-145.
10. Koh A, Senior P, Salam A, et al. Insulin-heparin infusions peritransplant substantially improve single-donor clinical transplant success. Transplantation 2010; 89: 465-471.
11. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W., Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 1995; 18: 517-522.
12. Gold AE, MacLeod KM, Frier BM., Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994; 17: 697-703.
13. Greenbaum CJ, Mandrup-Poulsen T, McGee PF, et al. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 2008; 31: 1966-1971.
14. Kessler L, Bucher P, Milliat-Guittard L, et al. Influence of islet transportation on pancreatic islet allotransplantation in type 1 diabetic patients within the Swiss-French GRAGIL network. Transplantation 2004; 77: 1301-1304.
15. Barshes NR, Lee T, Goodpasture S, et al. Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: A first-year review. Transplant Proc 2004; 36: 1127-1129.
16. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830-835.
17. Lehmann R, Spinas GA, Moritz W, Weber M., Has time come for new goals in human islet transplantation ? Am J Transplant 2008; 8: 1096-1100.
18. White SA, Shaw JA, Sutherland DE., Pancreas transplantation. Lancet 2009; 373: 1808-1817.
19. Gerber PA, Pavlicek V, Demartines N, et al. Simultaneous islet-kidney vs pancreas-kidney transplantation in type 1 diabetes mellitus: A 5 year single centre follow-up. Diabetologia 2008; 51: 110-119.
20. Hudson AJ, Fuggle SV, Friend PJ, Watson CJE., MO-017. The UK National Pancreas Allocation Scheme [Abstract presentation at European Society for Organ Transplantation Annual Conference Glasgow UK], 2011. Conference Timetable. Available at: http://www.esot.org/congresses/glasgow/content.aspx?item=70. Accessed December 16, 2012.
21. Rickels MR, Liu C, Shlansky-Goldberg RD, et al. Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol. Diabetes 2013; 62: 2890-2897.
22. Bellin MD, Barton FB, Heitman A, et al. Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am J Transplant 2012; 12: 1576-1583.
23. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.